Home / Insurers / Highmark

HighmarkDenial Rates & Appeal Data

Medicare AdvantageMedicaid MCOMarketplace QHPCommercialReporting year 2025

Compare against every insurer we track: denial rates ranked within reporting cohorts.

Prior-auth denial rate
4.8%
of Medicare Advantage, Medicaid, and Marketplace reporting units requests denied
PA requests
1.1M
reported within the published scope for 2025

COVERAGE RIGHTS ROLLUP · CALCULATED FROM HIGHMARK PUBLIC DISCLOSURES

Rollup computed from Highmark's enterprise per-contract report where request counts are posted (12 of 14 reporting units: 8 Medicare Advantage contracts plus state Medicaid and marketplace units; 2 percentage-only units excluded). Combined standard+expedited basis (4.2% standard, 7.2% expedited). Appeal counts are not published at the enterprise level, so no overturn rate is derivable.

UNDERLYING SOURCE: HIGHMARK CMS-0057-F DISCLOSURE, CY2025 · VIEW SOURCE ↗ · METHODOLOGY

Metrics by contract / plan

Highmark’s own CY2025 CMS-0057-F disclosures, plan by plan. Standard-request figures; every row links to its source.
Highmark CY2025 prior authorization metrics by contract or plan
Contract / planLineRequestsDeniedAppeals overturnedAvg decisionSource
H3916Medicare Advantage463,352
4%
n/rn/r
qhp-issuer-levelMarketplace120,652
8%
n/rn/r
H3957Medicare Advantage98,307
3%
n/rn/r
H5106Medicare Advantage41,018
5%
n/rn/r
H3384Medicare Advantage39,409
1%
n/rn/r
medicaid-ffs-DE · DEMedicaid32,291
1%
n/r3.8d
H8166Medicare Advantage27,105
4%
n/rn/r
H5526Medicare Advantage25,925
1%
n/rn/r
medicaid-ffs-PA · PAMedicaid22,141
4%
n/r1.48d
H5932 · PAMedicare Advantage7,010
12%
n/r4.74d
medicaid-ffs-WV · WVMedicaid1,426
4%
n/rn/r
H7710 · DEMedicare Advantage671
12%
n/r4.8d
medicaid-ffs-NY · NYMedicaidn/r
8.7%
n/r2d
medicaid-mco-plan-levelMedicaid MCOn/r
2%
n/r2.07d
N/R = NOT REPORTED · COLLECTED 2026-07-19 FROM HIGHMARK’S PUBLISHED DISCLOSURES

Your appeal deadline depends on your plan type

Highmark runs several kinds of plans, and the appeal rules follow the plan, not the insurer. Find the ladder and the deadlines for yours:

Medicare Advantage appeal rightsMedicaid appeal rightsACA / Marketplace appeal rightsEmployer plan (ERISA) appeal rights

Common questions

What is Highmark's prior authorization denial rate?

Coverage Rights calculated a 4.8% prior-authorization denial rate for the Medicare Advantage, Medicaid, and Marketplace reporting units reporting scope in 2025, using the public disclosure required by federal rule CMS-0057-F.

How do I appeal a Highmark denial?

Start with the appeal instructions in Highmark's denial notice. An independent external, fair-hearing, or Medicare review may be available after the required internal review, but eligibility depends on the coverage program, plan funding, denial type, regulating jurisdiction, and whether the notice says internal review is exhausted. Use the pathway tool before choosing the next reviewer.

Where do these numbers come from?

Coverage Rights calculated the displayed rollup from Highmark's public CMS-0057-F disclosures for 2025. The methodology note identifies the included reporting scope and weighting or aggregation method; source links lead to the underlying insurer-published records.

Denied by Highmark? An initial denial can be appealed. Build a clear, evidence-backed response.

How to appealStart my appeal